122 related articles for article (PubMed ID: 21103622)
1. Ki-67 expression in gastric cancer. Results from a prospective study with long-term follow-up.
Lazăr D; Tăban S; Sporea I; Dema A; Cornianu M; Lazăr E; Goldiş A; Vernic C
Rom J Morphol Embryol; 2010; 51(4):655-61. PubMed ID: 21103622
[TBL] [Abstract][Full Text] [Related]
2. The immunohistochemical expression of the p53-protein in gastric carcinomas. Correlation with clinicopathological factors and survival of patients.
Lazăr D; Tăban S; Sporea I; Dema A; Cornianu M; Lazăr E; Goldiş A; Raţiu I; Vernic C
Rom J Morphol Embryol; 2010; 51(2):249-57. PubMed ID: 20495739
[TBL] [Abstract][Full Text] [Related]
3. Gastric cancer: correlation between clinicopathological factors and survival of patients. II.
Lazăr D; Tăban S; Sporea I; Dema A; Cornianu M; Lazăr E; Goldiş A; Vernic C
Rom J Morphol Embryol; 2009; 50(2):185-94. PubMed ID: 19434309
[TBL] [Abstract][Full Text] [Related]
4. The potential role of Bcl-2 expression, apoptosis and cell proliferation (Ki-67 expression) in cases of gastric carcinoma and correlation with classic prognostic factors and patient outcome.
Tsamandas AC; Kardamakis D; Tsiamalos P; Liava A; Tzelepi V; Vassiliou V; Petsas T; Vagenas K; Zolota V; Scopa CD
Anticancer Res; 2009 Feb; 29(2):703-9. PubMed ID: 19331225
[TBL] [Abstract][Full Text] [Related]
5. Immunohistochemical evaluation of Ki-67, PCNA and MCM2 proteins proliferation index (PI) in advanced gastric cancer.
Czyzewska J; Guzińska-Ustymowicz K; Pryczynicz A; Kemona A; Bandurski R
Folia Histochem Cytobiol; 2009; 47(2):289-96. PubMed ID: 19995716
[TBL] [Abstract][Full Text] [Related]
6. [Immunohistochemical study on the prognostic value of the expression of laminin and Ki-67 receptors in advanced gastric cancer].
de Manzoni G; Guglielmi A; Di Leo A; Tomezzoli A; Laterza E; Bonfiglio M; Biolo S; Tedesco P; Borzellino G
G Chir; 1998; 19(8-9):323-8. PubMed ID: 9734182
[TBL] [Abstract][Full Text] [Related]
7. Gastric cancer: correlation between clinicopathological factors and survival of patients (III).
Lazăr D; Tăban S; Sporea I; Dema A; Cornianu M; Lazăr E; Goldiş A; Vernic C
Rom J Morphol Embryol; 2009; 50(3):369-79. PubMed ID: 19690762
[TBL] [Abstract][Full Text] [Related]
8. High expression of L-type amino-acid transporter 1 (LAT1) in gastric carcinomas: comparison with non-cancerous lesions.
Ichinoe M; Mikami T; Yoshida T; Igawa I; Tsuruta T; Nakada N; Anzai N; Suzuki Y; Endou H; Okayasu I
Pathol Int; 2011 May; 61(5):281-9. PubMed ID: 21501294
[TBL] [Abstract][Full Text] [Related]
9. Clinicopathological and prognostic significance of p53, Ki-67, and Bcl-2 expression in Tunisian gastric adenocarcinomas.
Ayed DB; Khabir A; Abid M; Bayrouti MI; Gargouri A; Sellami-Boudawara T; Mokdad-Gargouri R
Acta Histochem; 2014 Oct; 116(8):1244-50. PubMed ID: 25095748
[TBL] [Abstract][Full Text] [Related]
10. Immunohistochemical evaluation of the tumor neoangiogenesis as a prognostic factor for gastric cancers.
Lazăr D; Tăban S; Raica M; Sporea I; Cornianu M; Goldiş A; Vernic C
Rom J Morphol Embryol; 2008; 49(2):137-48. PubMed ID: 18516318
[TBL] [Abstract][Full Text] [Related]
11. Ki-67 (MIB1), p53, and Lewis-X (LeuM1) as prognostic factors of recurrence in T1 and T2 laryngeal carcinoma.
Sittel C; Eckel HE; Damm M; von Pritzbuer E; Kvasnicka HM
Laryngoscope; 2000 Jun; 110(6):1012-7. PubMed ID: 10852523
[TBL] [Abstract][Full Text] [Related]
12. The immunohistochemical expression of E-cadherin in gastric cancer; correlations with clinicopathological factors and patients' survival.
Lazăr D; Tăban S; Ardeleanu C; Dema A; Sporea I; Cornianu M; Lazăr E; Vernic C
Rom J Morphol Embryol; 2008; 49(4):459-67. PubMed ID: 19050793
[TBL] [Abstract][Full Text] [Related]
13. Ki-67 as a prognostic marker in colorectal cancer but not in gastric cancer.
Oshima CT; Iriya K; Forones NM
Neoplasma; 2005; 52(5):420-4. PubMed ID: 16151588
[TBL] [Abstract][Full Text] [Related]
14. Paradoxical expression of maspin in gastric carcinomas: correlation with carcinogenesis and progression.
Yu M; Zheng H; Tsuneyama K; Takahashi H; Nomoto K; Xu H; Takano Y
Hum Pathol; 2007 Aug; 38(8):1248-55. PubMed ID: 17490717
[TBL] [Abstract][Full Text] [Related]
15. Immunohistochemical expression of the cyclooxygenase-2 (COX-2) in gastric cancer. The correlations with the tumor angiogenesis and patients' survival.
Lazăr D; Tăban S; Ardeleanu C; Simionescu C; Sporea I; Cornianu M; Vernic C
Rom J Morphol Embryol; 2008; 49(3):371-9. PubMed ID: 18758643
[TBL] [Abstract][Full Text] [Related]
16. Correlations between Her2 oncoprotein, VEGF expression, MVD and clinicopathological parameters in gastric cancer.
Bădescu A; Georgescu CV; Vere CC; Crăiţoiu S; Grigore D
Rom J Morphol Embryol; 2012; 53(4):997-1005. PubMed ID: 23303024
[TBL] [Abstract][Full Text] [Related]
17. Aberrant expression of cortactin and fascin are effective markers for pathogenesis, invasion, metastasis and prognosis of gastric carcinomas.
Li X; Zheng H; Hara T; Takahashi H; Masuda S; Wang Z; Yang X; Guan Y; Takano Y
Int J Oncol; 2008 Jul; 33(1):69-79. PubMed ID: 18575752
[TBL] [Abstract][Full Text] [Related]
18. Overexpression of GRP78 and GRP94 are markers for aggressive behavior and poor prognosis in gastric carcinomas.
Zheng HC; Takahashi H; Li XH; Hara T; Masuda S; Guan YF; Takano Y
Hum Pathol; 2008 Jul; 39(7):1042-9. PubMed ID: 18482745
[TBL] [Abstract][Full Text] [Related]
19. Mutated p53 protein expression and proliferative activity in advanced gastric cancer.
Ikeguchi M; Saito H; Kondo A; Tsujitani S; Maeta M; Kaibara N
Hepatogastroenterology; 1999; 46(28):2648-53. PubMed ID: 10522058
[TBL] [Abstract][Full Text] [Related]
20. Identification of high-risk patients by assessment of nuclear Ki-67 expression in a prospective study of endometrial carcinomas.
Salvesen HB; Iversen OE; Akslen LA
Clin Cancer Res; 1998 Nov; 4(11):2779-85. PubMed ID: 9829742
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
